London: September 13, 2020. Saturday din Pharma giant AstraZeneca para koishe ke, Covid-19 vaccine trial kam aro soruh hoishe. Tai khan British regulators para kam sob clear hoishe. Kam roka toh UK volunteer bemar howah beche thakishe koishe. “Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, toh UK te aro kam soruh hoishe, Medicines Health Regulatory Authority (MHRA) confirmation thishe aro kam soruh koriboli safe ase” koikena statement te company para janai thishe. Wednesday din, AstraZeneca para “voluntarily paused” junai thishe ke, tai khan volunteer logot bemar hoikena Oxford University para vaccine bonaithaka trial kora samay rokishe. Safety saboli nemite independent committee ekta bonaishe. Company aro World Health Organization para routine step lobo nemite ase koishe. “Committee khan para investigation kora kotom hoikena MHRA logot UK te trials koriboli safe ase etu para kam toh aro soruh koribo”, koikena AstraZeneca para koishe. AstraZeneca’s vaccine candidate toh duniyaa laga nouta(9) pithor te ekta ase aro tai khan etai late-stage Phase 3 human trials jaiase koishe. United States te, company para August 31 darik te 30,000 volunteers khan laga nam thalishe aro etu vaccine toh Brazil aro South America te manuh khan logot test koriase koishe. Vaccine deya beche, manuh laga body pithor te protein bonai, aro etu te immune system para judi bemar hoile, coronavirus logot larai kori koishe. “AstraZeneca toh trial kora manuh ke safety dey aro etu clinical trails samay sobse highest standard ase” koikena Saturday laga statement te koishe. “duniyaa sob te, company aro health authorities melikena kam koribo aro ketai dosura clinical trials para vaccine olabo, health authorities para motob koribo aro bemari samay tai khan laap nalobo koishe”.
Add Comment